BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $2.07B (100.0% shares, 0.0% debt)

Holdings (6)

G GENPACT LIMITED 43.3%

Value $897M Shares 23,537,808 Share Price $38.09 Est. Cost/Share — Unrealized @ Report Date —

— MICHAELS COS INC 22.2%

Value $459M Shares 52,798,929 Share Price $8.70 Est. Cost/Share — Unrealized @ Report Date —

IQV IQVIA HLDGS INC 15.7%

Value $324M Shares 2,015,534 Share Price $160.90 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 10.4%

Value $215M Shares 26,455,651 Share Price $8.14 Est. Cost/Share — Unrealized @ Report Date —

— ATENTO S A 5.8%

Value $121M Shares 48,520,671 Share Price $2.49 Est. Cost/Share — Unrealized @ Report Date —

— VERITIV CORP 2.6%

Value $54.06M Shares 2,783,840 Share Price $19.42 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
G	GENPACT LIMITED	23,537,808	$897M	43.3%	$38.09	—	—	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$459M	22.2%	$8.70	—	—	COM	59408Q106
IQV	IQVIA HLDGS INC	2,015,534	$324M	15.7%	$160.90	—	—	COM	46266C105
SGRY	SURGERY PARTNERS INC	26,455,651	$215M	10.4%	$8.14	—	—	COM	86881A100
—	ATENTO S A	48,520,671	$121M	5.8%	$2.49	—	—	SHS	L0427L105
—	VERITIV CORP	2,783,840	$54.06M	2.6%	$19.42	—	—	COM	923454102